Meta-Analysishigh evidence

Efficacy and Safety of Radiofrequency as a Treatment Modality for Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

International urogynecology journal·July 30, 2026·PMID 42530648

Why it matters

GSM affects many postmenopausal women, yet adherence to existing treatments like vaginal estrogen is often limited. RF therapy offers a non-hormonal option that may improve sexual function without serious adverse events, expanding the therapeutic toolkit for clinicians managing menopause-related sexual health concerns.

Infographic summary of Efficacy and Safety of Radiofrequency as a Treatment Modality for Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled